Model Number G124 |
Device Problems
Under-Sensing (1661); Delayed Charge Time (2586)
|
Patient Problem
Syncope/Fainting (4411)
|
Event Date 08/07/2023 |
Event Type
Injury
|
Event Description
|
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) exhibited undersensing on the right ventricular channel during an intrinsic ventricular tachycardia episode, in which the patient also experienced a syncope.The device was able to deliver appropriately one shock, ending the episode.However, it was noted that, due to this undersensing, the therapy could have been delivered slightly sooner (less than one second).Reprograming of the device was discussed.This device remains in service.No further adverse patient effects were reported.Additional information was received detailing that this device was explanted and replaced.
|
|
Manufacturer Narrative
|
The returned device was thoroughly inspected and analyzed upon receipt at our post market quality assurance laboratory.Visual examination of the device header and case noted no anomalies.The device was then exposed to simulated heart load conditions, and the defibrillation, pacing, and sensing functions were tested.Impedance testing was completed and all measurements were within normal limits.The device operated appropriately with no interruptions in therapy output at the returned programmed settings.A series of electrical tests was also performed, and again, normal device function was observed.Analysis did not identify any device characteristics that would have caused or contributed to the reported clinical observations.
|
|
Event Description
|
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) exhibited undersensing on the right ventricular channel during an intrinsic ventricular tachycardia episode, in which the patient also experienced a syncope.The device was able to deliver appropriately one shock, ending the episode.However, it was noted that, due to this undersensing, the therapy could have been delivered slightly sooner (less than one second).Reprograming of the device was discussed.This device remains in service.No further adverse patient effects were reported.Additional information was received detailing that this device was explanted and replaced.This device was returned to boston scientific for analysis.
|
|
Search Alerts/Recalls
|
|